VE
VENKER ERIC disclosed sale in Roivant Sciences Ltd.
VENKER ERIC, President & Immunovant CEO, disclosed a sale transaction in Roivant Sciences Ltd. (ROIV) on 2026-05-22.
Action
Sale
Capital
$6.1 million reported value
Insider Form 4 Activity1 evidence source
Why it matters
Insider Form 4 disclosures can surface management and director trading activity. This card is generated from pre-ingested disclosure data, not from request-time scraping.